My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
CORRESPONDENCE - 60B
Clerk
>
Agenda Packets / Staff Reports
>
City Council (2004 - Present)
>
2020
>
09/15/2020
>
CORRESPONDENCE - 60B
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/15/2020 4:38:43 PM
Creation date
9/14/2020 11:45:26 AM
Metadata
Fields
Template:
City Clerk
Doc Type
Agenda Packet
Item #
60B
Date
9/15/2020
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
14
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
SEP obtained syringes. "PWID who utilized pharmacies as their primary source of syringes <br />8 <br />were 1.5 times as likely to have disposed of used syringes unsafely in the past 12 months." <br />Rather than ban the single most effective tool against syringe litter, the Santa Ana City <br />Council should do everything they can to support the proper operations of multiple accessible <br />SEP sites. <br /> <br /> <br />II. Similar Bans and Restrictions Have Been Struck Down as Violations of the ADA <br /> <br />In bringing forth a facial challenge under Title II of the ADA, the plaintiff must establish <br />that (1) qualified individuals with a disability (2) have been subjected to discrimination by a <br />public entity (3) by reason of their disability. Past litigation successfully challenging <br />discriminatory zoning ordinances establishes the applicability of this framework to treatment <br />facilities serving patients with SUD. Numerous courts have held that laws that single out opioid <br />treatment programs are facially discriminatory under the ADA and the RA; below is only a brief <br />overview of this line of jurisprudence. <br />Twenty years ago, the Ninth Circuit established that the ADA and the RA apply to <br />restrictions targeting substance use treatment facilities because zoning “is a normal function of <br />9 <br />a governmental entity.” The Court reasoned that the “sweeping language <br />\[of the ADA\] — most noticeably Congress’s analogizing the plight of the disabled to that of <br />discrete and insular minorit\[ies\]’ like racial minorities— strongly suggests that §12132 should not <br />be construed to allow the creation of spheres in which public entities may discriminate on the <br />1011 <br />basis of an individual’s disability.” Since then, the Third and Sixth Circuits have followed suit. <br />In its seminal decision, the Ninth Circuit struck down an emergency moratorium prohibiting the <br />operation of methadone clinics within 500 feet of residential areas as facially discriminatory on <br />the basis of the plaintiff’s disability and a per se violation of Title II of the Americans with <br />12 <br />Disabilities Act. <br />Three years later, the Sixth Circuit invalidated an ordinance limiting the number of all <br />SUD treatment clinics to one facility for every 20,000 persons in the city, finding that “the blanket <br />prohibition of all methadone clinics from the entire city is discriminatory on its face” in violation of <br />13 <br />the Americans with Disabilities Act. Similarly, the Third Circuit struck down a state statute <br />imposing a ban on the establishment of SUD treatment clinics within 500 feet of schools, <br />churches, and residential housing developments, holding that the statute “facially singles out <br />methadone clinics, and thereby methadone patients, for different treatment, thereby rendering <br />14 <br />the statute facially discriminatory.” There are a number of other cases where the ADA and RA <br /> <br />8 <br /> Zlotorzynska, M., Weidle, P. J., Paz-Bailey, G., & Broz, D. (2018). Factors associated with obtaining sterile syringes from <br />pharmacies among persons who inject drugs in 20 US cities. International Journal of Drug Policy, 62, 51–58. <br />https://doi.org/10.1016/j.drugpo.2018.08.019 <br />9 <br /> Bay Area Addiction Research & Treatment, Inc. v. City of Antioch, 179 F.3d 725, 731 (9th Cir. 1999). <br />10 <br /> Id. <br />11 <br /> New Directions Treatment Servs. v. City of Reading, 490 F.3d 293 (3d Cir. 2007); MX Group, Inc. v. City of Covington, 293 F.3d <br />326, 342 (6th Cir. 2002). <br />12 <br /> Bay Area Addiction Research & Treatment, Inc. v. City of Antioch, 179 F.3d 725, 737 (9th Cir. 1999). <br />13 <br /> MX Group, Inc. v. City of Covington, 293 F.3d 326, 345 (6th Cir. 2002). <br />14 <br /> New Directions Treatment Servs. v. City of Reading, 490 F.3d 293, 304, 307 (3d Cir. 2007). <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.